Suggestions
Sam Kongsamut
Biopharmaceutical Entrepreneur
Sam Kongsamut is an accomplished biopharmaceutical industry scientist and business development professional with extensive experience in project progression, fundraising, and partnering for innovative projects in the biotech and pharma sectors.
He has a strong background in promoting entrepreneurship and innovation in Life Sciences, providing mentorship, advisory services, and training programs to support the growth of the entrepreneurial ecosystem.
As a former external innovation specialist in aging, age-related, and neuroscience/CNS disorders, Sam focused on in-licensing and establishing collaborative networks with academia and biotechnology companies, contributing significantly to deal-making processes.
With a deep understanding of neurosciences, particularly in neuropsychiatric diseases, translational medicine, and clinical studies, Sam has led multidisciplinary teams in developing compounds through various phases up to market launch.
His expertise includes managing project portfolios, overseeing teams of scientists working on ion channels, G-protein coupled receptors, and enzymes, and driving pharmaceutical R&D initiatives.
Sam's educational background includes a Ph.D. from the University of Chicago, an MS from the University of Illinois at Chicago, and a BSc from the University of Ottawa. He also studied at Ruam Rudi International School in Bangkok and Rutgers Business School.
Throughout his career, Sam has held key positions in prestigious organizations, such as Co-founder and Vice-President of Research & Development at BryoLogyx, Vice President of Business Development at BioInvenu Corporation, and President at Rudder Serendip LLC.
He has also served in advisory and executive roles at institutions like the Institute For Life Science Entrepreneurship, Research Institute for Scientists Emeriti at Drew University, Neurotrope Bioscience, and Columbia University.
Additionally, Sam has a strong background in academia, having engaged in research and postdoctoral fellowships at esteemed universities like Yale and Cornell, further enriching his expertise in pharmacology and neuroscience.
As an industry mentor and executive-in-residence, Sam has been actively involved in fostering open innovation, scouting for new opportunities, and driving entrepreneurship initiatives within the pharmaceutical and biotech sectors.
